Study of AZD3152 intramuscular injection or intravenous infusion in Healthy Japanese Adult Participants

Trial Identifier: D7000C00007
Sponsor: AstraZeneca
NCTID:: NCT05932641
Start Date: July 2023
Primary Completion Date: December 2024
Study Completion Date: December 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
JP Fukuoka-shi, JP, 812-0025